Answers are grounded in this paper and cite their sources.
Medicinal plant byproducts are increasingly considered as unconventional feed resources, yet their fermentation performance, digestibility, and safety require further evaluation. This study aimed to identify the best-performing additive treatment for Anisodus tanguticus byproduct silage through an integrated evaluation of fermentation quality, chemical composition, and digestibility after 45 d of ensiling and 48 h of in vitro ruminal incubation, with exploratory omics analyses to characterize associated metabolic and microbial profiles. Six selected treatments underwent untargeted metabolomic and metagenomic analyses with three biological replicates per stage. The combination of 4% molasses and a mixed Bacillus subtilis – Lacticaseibacillus paracasei inoculant (BSLPT 4 ) ranked highest in the comprehensive quality evaluation. Compared with the untreated control, BSLPT 4 lowered pH from 5.42 to 4.01 and NH 3 -N/TN from 15.14% to 10.30% ( P < 0.01), while increasing lactic acid concentration to approximately 10.9 times the control value. It also improved dry matter and neutral detergent fiber digestibility by 16.9% and 15.7%, respectively. These improvements coincided with higher relative abundances of features putatively annotated as hyoscyamine, anisodamine, and scopolamine. Selected alkaloid-associated features remained detectable after digestion and correlated with ruminal microbial taxa and digestibility, while metagenomic annotations identified candidate functions associated with alkaloid transformation. BSLPT 4 also exhibited lower relative abundances of selected capsule-associated virulence factors and antibiotic resistance genes during ensiling, with lower antibiotic resistance gene abundance persisting after digestion despite marked microbial community restructuring. Together, these findings link improved silage quality to distinct alkaloid-associated and microbial gene profiles across fermentation and digestion. They identify BSLPT 4 as a promising treatment for further evaluation of medicinal plant byproduct utilization. These findings are limited by the single-batch in vitro digestion design and the putative nature of the metabolite annotations. Confirmation and absolute quantification of key alkaloids, followed by in vivo dose–response feeding trials, are required to establish their physiological effects and toxicological safety.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: